0000000000242642

AUTHOR

Amparo Araico

showing 4 related works from this author

Evaluation of the anti-inflammatory and analgesic activity of Me-UCH9, a dual cyclooxygenase-2/5-lipoxygenase inhibitor

2007

Abstract Recently, we reported the dual inhibition of cyclooxygenase-2 (COX-2) and 5-lipoxygenase (5-LO) activity by some phenylsulphonyl urenyl chalcone derivatives. 2,4-dichloro-4′ N [ N ′(4″methylphenylsulphonyl)urenyl] chalcone (Me-UCH9), was selected in the present study to determine its potential anti-inflammatory and analgesic effect after oral administration in several animal models related to the activation of COX-2 and 5-LO pathways. In the zymosan stimulated mouse air pouch model, Me-UCH9, reduced in a dose-dependent manner leukotriene B 4 (LTB 4 ) levels in pouch exudates obtained at 4 h, as well as prostaglandin E 2 (PGE 2 ) generated through COX-2 activation at 24 h. Tumor nec…

Chalconemedicine.drug_classStereochemistrymedicine.medical_treatmentAnalgesicAnti-Inflammatory AgentsArthritisPharmacologyCarrageenanGeneral Biochemistry Genetics and Molecular BiologyAnti-inflammatoryMicechemistry.chemical_compoundChalconesOral administrationmedicineAnimalsEdemaHumansCyclooxygenase InhibitorsLipoxygenase InhibitorsEnzyme InhibitorsRats WistarGeneral Pharmacology Toxicology and PharmaceuticsAnalgesicsDose-Response Relationship Drugbiologybusiness.industryZymosanGeneral Medicinemedicine.diseaseArthritis ExperimentalRatschemistryCyclooxygenase 2biology.proteinFemaleCyclooxygenasebusinessProstaglandin ELife Sciences
researchProduct

Effect of cytochrome P450 inhibitors (diethyl dithiocarbamate, ketoconazole and grapefruit juice) on the pharmacokinetics of all-trans-retinoic acid.

2004

Diethyl dithiocarbamate (DEDTC) has been reported to be a more powerful inhibitor of all-trans-retinoic acid (ATRA) in vitro metabolism than the well-established cytochrome P450 (CYP) inhibitor ketoconazole (KC). In recent years grapefruit juice (GJ) has been shown to be able to increase the oral bioavailability of several drugs by inhibiting intestinal CYP. This study investigated the in vivo effect of these CYP inhibitors on the pharmacokinetics of ATRA. The latter was administered to rats as a constant-rate intravenous (i.v.) infusion (0.48 mg h(-1) kg(-1)) during 10 h and orally (1.6 mg kg(-1)). DEDTC (320 mg kg(-1) x 2 i.v., 6.4 and 32 mg kg(-1) per os (p.o.)) did not change the ATRA c…

food.ingredientRetinoic acidPharmaceutical ScienceTretinoinPharmacologyGrapefruit juiceBeverageschemistry.chemical_compoundfoodPharmacokineticsCytochrome P-450 Enzyme SystemIn vivoDrug DiscoverymedicineAnimalsCytochrome P-450 Enzyme InhibitorsEnzyme InhibitorsneoplasmsCytochrome P-450 Enzyme Inhibitorsbiologyorganic chemicalsCytochrome P450BioavailabilityRatsKetoconazolechemistrybiology.proteinKetoconazoleDitiocarbmedicine.drugCitrus paradisiFarmaco (Societa chimica italiana : 1989)
researchProduct

Phenylsulphonyl urenyl chalcone derivatives as dual inhibitors of cyclo-oxygenase-2 and 5-lipoxygenase

2005

Two series of phenylsulphonyl urenyl chalcone derivatives (UCH) with various patterns of substitution were tested for their effects on nitric oxide (NO) and prostaglandin E2 (PGE2) overproduction in RAW 264.7 macrophages. None of the tested compounds reduced NO production more than 50% at 10 microM but most of them inhibited the generation of PGE2 with IC50 values under the micromolar range. Me-UCH 1, Me-UCH 5, Me-UCH 9, Cl-UCH 1, and Cl-UCH 9 were selected to evaluate their influence on human leukocyte functions and eicosanoids generation. These derivatives selectively inhibited cyclo-oxygenase-2 (COX-2) activity in human monocytes being Me-UCH 5 the most potent (IC50 0.06 microM). Selecte…

ChalconeNeutrophilsNitric OxideLeukotriene B4DinoprostoneGeneral Biochemistry Genetics and Molecular BiologyCell LineNitric oxideMiceStructure-Activity Relationshipchemistry.chemical_compoundChalconesmedicineAnimalsHumansCyclooxygenase InhibitorsLipoxygenase InhibitorsGeneral Pharmacology Toxicology and PharmaceuticsProstaglandin E2IC50Molecular StructurebiologySuperoxideMacrophagesElastaseGeneral MedicinechemistryBiochemistryCyclooxygenase 2MyeloperoxidaseArachidonate 5-lipoxygenasebiology.proteinmedicine.drugLife Sciences
researchProduct

Role of nuclear factor-κB and heme oxygenase-1 in the mechanism of action of an anti-inflammatory chalcone derivative in RAW 264.7 cells

2004

The synthetic chalcone 3',4',5',3,4,5-hexamethoxy-chalcone (CH) is an anti-inflammatory compound able to reduce nitric oxide (NO) production by inhibition of inducible NO synthase protein synthesis. In this work, we have studied the mechanisms of action of this compound. CH (10-30 microm) prevents the overproduction of NO in RAW 264.7 macrophages stimulated with lipopolysaccharide (1 microg ml(-1)) due to the inhibition of nuclear factor kappaB (NF-kappaB) activation. We have shown that treatment of cells with CH results in diminished degradation of the NF-kappaB-IkappaB complex leading to inhibition of NF-kappaB translocation into the nucleus, DNA binding and transcriptional activity. We a…

PharmacologyOxygenaseChalconebiologyChemistryNFKB1Nitric oxideHeme oxygenaseNitric oxide synthasechemistry.chemical_compoundBiochemistryMechanism of actionmedicinebiology.proteinmedicine.symptomHemeBritish Journal of Pharmacology
researchProduct